BIOLABO

BIOLABO is an independent French in vitro diagnostics company that develops, manufactures, and markets clinical chemistry, coagulation, immunoturbidimetry, and slide-test reagents, along with laboratory analyzers and related controls and calibrators. The company has operated for more than 40 years and serves laboratories primarily through an international distributor network, exporting most of its production. BIOLABO is part of BIOLABO GROUP and positions itself as a manufacturer with capabilities spanning both reagents and analyzers, strengthened by the acquisition of BPC BioSed. Its branded analyzer portfolio includes the KENZA and SOLEA ranges, and the group also references antibody manufacturing through ABLIANCE. The business is focused on routine diagnostic testing rather than therapeutic drug development.